Sector Expert: Adam Schatzker

Research Capital Corporation

Subscribe to
Streetwise Reports

Companies Commented On



Recent Quotes

"We are initiating coverage on EMPR with a Buy rating. . .2022 is set to be a turning point year for the company as all three of its assets are expected to begin producing revenues."

— Adam Schatzker, Research Capital Corporation (7/5/21)
more >

"Recent court events regarding Aznalcóllar look quite positive for EMO."

— Adam Schatzker, Research Capital Corporation (6/24/21)
more >

"We are initiating coverage on EMO. . .we think it is an excellent exploration vehicle for investors seeking exposure to high-quality zinc exploration assets with excellent infrastructure, a solid mining culture and low political risk."

— Adam Schatzker, Research Capital Corporation (6/15/21)
more >

"GENM and Sibanye-Stillwater approved the Marathon feasibility study."

— Adam Schatzker, Research Capital Corporation (4/30/21)
more >

"GENM's feasibility study provides greater detail and granularity."

— Adam Schatzker, Research Capital Corporation (3/26/21)
more >

"GENM's Marathon project will likely attract a number of companies."

— Adam Schatzker, Research Capital Corporation (3/8/21)
more >

"GENM engaged a drilling contractor for a 3,000m drill program."

— Adam Schatzker, Research Capital Corporation (2/23/21)
more >

"We are initiating coverage on GENM with a Speculative Buy. . .Generation offers investors one of the few advanced palladium projects that could be shovel-ready in the coming three to four years."

— Adam Schatzker, Research Capital Corporation (2/12/21)
more >



Due to permission requirements, not all quotes are shown.